Skip to Content

CL 403 (Nevirapine Extended-Release 400 mg)

Pill with imprint CL 403 is Yellow, Capsule-shape and has been identified as Nevirapine Extended-Release 400 mg. It is supplied by Cipla USA Inc..

Nevirapine is used in the treatment of hiv infection; reduction of perinatal transmission of hiv and belongs to the drug class NNRTIs. There is no proven risk in humans during pregnancy. Nevirapine 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CL 403

Nevirapine Extended-Release

Imprint:
CL 403
Strength:
400 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
NNRTIs
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Cipla USA Inc.
National Drug Code (NDC):
69097-0403

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide